Papers Unplugged: Precision Medicine in AML
In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise treatments based on the characteristics of the leukemic cells in acute myeloid leukemias. Discover the clinical developments of targeted treatments such as IDH1/2 inhibitors and venetoclax, and learn about the importance of combination treatment to improve results.
The podcast also explores the use of epigenetic agents as part of standard care in older patients and how the proportion of patients treated with targeted agents is increasing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.